Aragen Life Sciences Ltd. excels in providing
end-to-end drug discovery and development solutions,
showcasing its innovative approaches and strong commitment to
sustainability and customer satisfaction.
SAN
ANTONIO, July 24, 2024 /PRNewswire/ -- Frost
& Sullivan has recognized Aragen Life Sciences, a world-class
contract research, development, and manufacturing organization
(CRDMO), with the 2024 Global Customer Value Leadership Award.
With nearly 25 years of experience, Aragen assists its global
clients in various industries, such as pharmaceutical, biotech, and
agrochemical, throughout the biopharmaceutical lifecycle, offering
comprehensive solutions spanning small and large molecules.
The company provides highly customized services tailored to meet
client requirements and leverages cutting-edge technologies, such
as artificial intelligence and machine learning, to drive its
discovery and development projects to commercialization.
It also focuses on sustainability through initiatives like
carbon-neutral programs and green chemistry, underscoring its
dedication to environmental responsibility.
Mani Kantipudi, CEO of Aragen
Life Sciences, said, "We are honored to receive the
2024 Global Customer Value Leadership Award from Frost &
Sullivan. This recognition reflects our relentless pursuit of
excellence and innovation in delivering value to our clients. We
remain committed to advancing the forefront of drug discovery and
development while upholding the highest standards of quality and
sustainability."
"Frost & Sullivan commends Aragen's impressive customer
centricity, which is evident in its tailored approach to meeting
diverse client needs, commitment to transparency and trust through
collaborative partnerships, and dedication to ensuring customer
satisfaction at every engagement stage. By adapting its strategies
to address individual pain points, assigning dedicated product
managers driven by customer feedback, and offering flexibility and
choice in service delivery, Aragen sets itself apart as a leader in
delivering exceptional customer experiences within the global life
sciences industry," said Khushbu Jain, Principal Consultant at Frost
& Sullivan.
Aragen's success is driven by a talented workforce of over 3,700
scientists worldwide, including 450+ PhDs, ensuring robust
scientific capabilities and operational efficiency. The company's
strategic investments and customer-centric approach have cemented
its reputation as a trusted partner in the life sciences
industry.
Each year, Frost & Sullivan presents this award to the
company that demonstrates excellence in implementing strategies
that proactively create value for its customers, focusing on
improving the return on investment that customers make in its
services or products. The award recognizes Aragen's unique focus on
augmenting customer value beyond simple good service, leading to
improved customer retention and an expanded base.
Frost & Sullivan Best Practices Awards recognize companies
in various regional and global markets for demonstrating
outstanding achievement and superior performance in leadership,
technological innovation, customer service, and strategic product
development. Industry analysts compare market participants and
measure performance through in-depth interviews, analyses, and
extensive secondary research to identify best practices in the
industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned
for its role in helping investors, corporate leaders, and
governments navigate economic changes and identify disruptive
technologies, megatrends, new business models, and companies to
action, resulting in a continuous flow of growth opportunities to
drive future success. Contact us: Start the discussion.
Contact:
Tarini Singh
P: +91- 9953764546
E: Tarini.Singh@frost.com
About Aragen
Aragen Life Sciences is a leading R&D and manufacturing
solutions provider to the global life sciences industries. It
offers a range of solutions across the drug development continuum
to advance small and large-molecule programs. The Company operates
through a global network of eight sites with a team of ~4,400
employees and 450+ PhDs. Its expertise and experience have enabled
over 400 customers to advance their research programs from early
discovery through development and commercialization. Aragen's
innovative mindset, infrastructure, flexible business models, clear
purpose, and proprietary project management platform have enabled
it to effectively scale and service large pharma, biotech,
agrochemical, and animal health industries globally. Visit
www.aragen.com for more details.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aragen-life-sciences-ltd-receives-the-2024-global-customer-value-leadership-award-from-frost--sullivan-for-pioneering-excellence-in-drug-discovery-and-development-services-302203856.html
SOURCE Frost & Sullivan